Pancreatic Cancer: Latest Insights into Early Spread and Future Treatment Strategies
Brazilian scientists at the São Paulo Research Foundation have uncovered key mechanisms driving the early spread of pancreatic cancer. Their research, published in Molecular and Cellular Endocrinology, identifies a protein called periostin, working alongside pancreatic stellate cells, as crucial in enabling cancer cells to invade nearby nerves.
The Perineural Invasion: A Critical Pathway
This invasion, known as perineural invasion, significantly increases the risk of metastasis and is strongly linked to the aggressiveness of the disease. The team utilized advanced tools to analyze the activity of thousands of genes within individual cells, precisely mapping their locations within the tumor tissue. They examined 24 pancreatic cancer samples, revealing that the stroma – the connective tissue supporting the tumor – isn’t passive, but actively contributes to disease progression.
Periostin’s Role in Remodeling the Tumor Environment
Pancreatic stellate cells produce substantial amounts of periostin, a protein known for its ability to remodel the extracellular matrix – the structure organizing and maintaining healthy tissues. Changes within this matrix allow tumor cells to traverse tissues and reach nearby nerves. Periostin facilitates this remodeling, effectively creating a “road” for cancer cells to spread.
Why Treatment is Challenging
The tumor microenvironment undergoes a desmoplastic reaction, leading to an accumulation of dense, fibrous tissue around the cancer mass. This stiffening and inflammation hinder the penetration of chemotherapy and immunotherapy drugs, allowing cancer cells to survive and continue spreading. The protective microenvironment is a major obstacle in treatment.
Rising Incidence and Current Statistics
Pancreatic cancer arises from the uncontrolled growth of cells within the pancreas, an organ responsible for producing hormones (like insulin and glucagon) and enzymes (like trypsin) essential for bodily functions. Diagnoses are increasing; in Italy, approximately 13,585 new cases were recorded in 2024, with 5-year survival rates of 11% for men and 12% for women. The cancer predominantly affects individuals between the ages of 50 and 80.
Types of Pancreatic Cancer
Around 70% of pancreatic cancers develop in the head of the organ and typically originate in the ducts carrying digestive enzymes. This is known as adenocarcinoma ductal of the pancreas, the most common and dangerous form. Less common are neuroendocrine carcinomas, which originate from cells within the islets of Langerhans.
Future Treatment Directions: Targeting Periostin
Scientists believe periostin represents a promising target for future treatments. Reducing its activity or removing the stellate cells that produce it could limit nerve invasion and slow cancer’s ability to spread. Further research is needed to fully understand these mechanisms.
The Potential of Stromal Targeting
The study highlights the importance of the tumor stroma as a therapeutic target. Traditionally, cancer treatment has focused on the cancer cells themselves. Though, understanding the role of the surrounding microenvironment, including stellate cells and proteins like periostin, opens new avenues for intervention.
Frequently Asked Questions
Q: What is perineural invasion?
A: It’s the process where cancer cells spread along nerves, increasing the risk of metastasis and making treatment more tough.
Q: What is the role of the stroma in pancreatic cancer?
A: The stroma, the connective tissue surrounding the tumor, actively promotes cancer progression rather than simply providing support.
Q: Is pancreatic cancer preventable?
A: While the exact cause isn’t known, avoiding smoking and maintaining a healthy weight can reduce risk.
Q: What are the common symptoms of pancreatic cancer?
A: Symptoms can be vague, but may include abdominal pain, weight loss, jaundice, and changes in stool.
Did you know? More than half of pancreatic cancer cases already show signs of perineural invasion at initial diagnosis, but this spread is often only discovered during surgery.
Pro Tip: Early detection is crucial for improving outcomes in pancreatic cancer. If you experience persistent abdominal pain or other concerning symptoms, consult a doctor immediately.
Explore more articles on cancer research and treatment options here. Subscribe to our newsletter for the latest updates in medical breakthroughs.
